search
Back to results

A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation

Primary Purpose

Chronic Kidney Disease, End-stage Renal Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Group-Based (GB) Intervention
Home-Based (HB) Intervention
Sponsored by
Beth Israel Deaconess Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Chronic Kidney Disease focused on measuring Live Donor Kidney Transplantation, LDKT, African Americans, Disparity, Education

Eligibility Criteria

21 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • African American race
  • male or female
  • 21 to 80 years old
  • diagnosis of ESRD
  • eligible for listing on the kidney transplant waiting list at Beth Israel Deaconess Medical Center
  • resides within 150 minutes of transplant center
  • residential or cell phone service
  • signed informed consent

Exclusion Criteria:

  • Wait-listed for additional organ transplant (i.e., heart, liver)
  • current substance abuse or dependency
  • known or suspected psychotic disorder
  • known or suspected mental retardation

Sites / Locations

  • Beth Israel Deaconess Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

No Intervention

Arm Label

Group Based

Home-Based

Standard Care

Arm Description

60-minute group session involving other study patients who have been assigned to this condition and their guests.

60-minute educational intervention in their home, which will be delivered by an African American health educator.

60-minute individual session with an African American health educator.

Outcomes

Primary Outcome Measures

The primary outcome for this study is the proportion of enrolled patients with live donor kidney transplants.

Secondary Outcome Measures

Higher proportion of enrolled patients with live donor inquiries and evaluations; and higher number of potential donors educated. Improvement in live donation knowledge, concerns, and willingness to initiate live donor discussion with others.

Full Information

First Posted
November 3, 2008
Last Updated
July 8, 2020
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
search

1. Study Identification

Unique Protocol Identification Number
NCT00785265
Brief Title
A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation
Official Title
A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
August 2007 (undefined)
Primary Completion Date
November 2015 (Actual)
Study Completion Date
June 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Beth Israel Deaconess Medical Center
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The main purpose of this study is to learn which educational method is most helpful to patients and their family members when they consider whether to pursue live donor kidney transplantation. Patients who are eligible for a kidney transplant usually get information in the transplant clinic about two types of kidney transplants - one where the kidney comes from a dead donor and one where the kidney comes from a healthy living donor. Patients are given this information by a transplant nurse or doctor and then encouraged to discuss it with family members and friends. In this study, we are trying to see if changing how and where we give patients this information makes a difference in how patients and their family members think about live donor kidney transplantation. So, we are looking at whether getting the information in the transplant clinic - either alone or in a group - is the same or different than getting the same information in your home. The study is only recruiting African American patients. This is being done because African Americans have a higher likelihood of developing chronic kidney disease and needing a kidney transplant than patients of other races. However, they wait longer for a kidney transplant and die at a higher rate on the waiting list because they are less likely than other patients to receive a live donor kidney transplant. We want to see which educational approach works best with African American patients and their families.
Detailed Description
Chronic kidney disease (CKD) affects over 10 million people in the United States. Diabetes, hypertension, glomerulonephritis, and polycystic kidney disease contribute to most cases of CKD. Those with CKD who become dialysis-dependent are considered to have ESRD. The incidence of ESRD has increased dramatically over the last decade and is estimated to be 338 per million population. Adults with ESRD are known to experience significant mortality and morbidity, and there is evidence of significant health disparities between Whites and ethnic minorities. While kidney transplantation is the treatment of choice for patients with ESRD, the waiting list and waiting time for deceased donor transplantation are expanding exponentially. Live donor kidney transplantation (LDKT) remains a viable option for patients, yet more than half of all wait-listed patients, especially minorities, do not pursue LDKT. Therefore, programs designed to further expand LDKT, especially those targeting minority populations, are needed given the current and projected shortage of deceased donor organs. The long-term goal of this research program is to improve education provided to African Americans and, thereby, increase rates of LDKT. The objective of this application is to determine the relative effectiveness of three strategies for increasing LDKT in African Americans. In a recently completed HRSA-funded (2002-2006) randomized clinical trial, we demonstrated that a home-based LDKT intervention program was superior to standard clinic-based education in increasing LDKT rates at one transplant center. The proposed study seeks to replicate and extend the evaluation of a home-based (HB) educational intervention in an African American patient population. The central hypothesis is that a HB intervention yields higher LDKT rates relative to other interventions in African Americans. This hypothesis has been formulated on the basis of strong preliminary data. The rationale for the proposed research is that, by identifying the interventions most likely to yield higher LDKT rates in African Americans, we can further develop and refine the interventional methodology that will allow the most effective education to be disseminated to all kidney transplant programs. We are especially well-prepared to conduct the proposed research due to the multidisciplinary nature of the research team, as well as the expertise and experience of the team in developing LDKT and live donation educational materials, implementing and evaluating novel LDKT interventions, conducting LDKT research with African Americans, and producing meaningful outcomes. Specifically, the research team includes investigators who are funded in the conduct of ESRD, kidney transplantation, and organ donation research and who are dedicated to the scientific advancement of LDKT. Also, the research will be conducted in an environment that is conducive to the successful completion of this project. To evaluate our central hypothesis and to accomplish the objective of the proposed study, we plan to pursue the following two specific aims: Specific Aim 1. Determine the clinical effectiveness of three separate LDKT educational approaches with African American patients. Recently, we found that an LDKT educational intervention delivered in the patient's home and that involved both patients and their invited guests (family, friends, community leaders) was an effective strategy for increasing LDKT, especially in African Americans. This is a very different educational approach than what is used in most transplant centers, which typically involves either group-based (patients and whomever accompanies them to clinic) meetings or individual patient sessions. Based on the work summarized in the Preliminary Studies section, the working hypothesis in this study is that patients randomized to a Home-Based (HB) intervention will demonstrate more favorable outcomes relative to patients randomized to a Group-Based (GB) intervention conducted in the transplant clinic or to a Standard Care (SC) condition in which individual patients are education in the transplant clinic. Specifically, relative to the GB or SC educational approaches, the HB intervention will demonstrate... Primary Outcome: Hypothesis 1.1: A higher proportion of enrolled patients with LDKTs. Secondary Outcomes: Hypothesis 1.2: A higher proportion of enrolled patients with live donor inquiries. Hypothesis 1.3: A higher proportion of enrolled patients with live donor evaluations. Hypothesis 1.4: A higher number of potential donors educated, per patient. Hypothesis 1.5: More improvement in live donation knowledge. Hypothesis 1.6: More improvement in live donation concerns. Hypothesis 1.7: More willingness to initiate live donor discussion with others. Specific Aim 2. Determine the sociodemographic, medical, and donation-specific variables that are most strongly associated with pursuing LDKT. Based on the work summarized in the Preliminary Studies section, the working hypothesis is that LDKT status (primary outcome: yes/no) will vary significantly by sociodemographic, medical, and donation-specific variables. Specifically… Hypothesis 2.1: The following patient characteristics will be significantly associated with having received LDKT: male, younger, dialysis-dependent, more live donor inquiries, more knowledge about live donation, fewer concerns about live donation, and more willingness to initiate live donation discussion with others.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Disease, End-stage Renal Disease
Keywords
Live Donor Kidney Transplantation, LDKT, African Americans, Disparity, Education

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
164 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group Based
Arm Type
Experimental
Arm Description
60-minute group session involving other study patients who have been assigned to this condition and their guests.
Arm Title
Home-Based
Arm Type
Active Comparator
Arm Description
60-minute educational intervention in their home, which will be delivered by an African American health educator.
Arm Title
Standard Care
Arm Type
No Intervention
Arm Description
60-minute individual session with an African American health educator.
Intervention Type
Behavioral
Intervention Name(s)
Group-Based (GB) Intervention
Intervention Description
60-minute group session involving other study patients who have been assigned to this condition and their guests.
Intervention Type
Behavioral
Intervention Name(s)
Home-Based (HB) Intervention
Intervention Description
60-minute educational intervention in their home, which will be delivered by an African American health educator.
Primary Outcome Measure Information:
Title
The primary outcome for this study is the proportion of enrolled patients with live donor kidney transplants.
Time Frame
one year
Secondary Outcome Measure Information:
Title
Higher proportion of enrolled patients with live donor inquiries and evaluations; and higher number of potential donors educated. Improvement in live donation knowledge, concerns, and willingness to initiate live donor discussion with others.
Time Frame
one year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: African American race male or female 21 to 80 years old diagnosis of ESRD eligible for listing on the kidney transplant waiting list at Beth Israel Deaconess Medical Center resides within 150 minutes of transplant center residential or cell phone service signed informed consent Exclusion Criteria: Wait-listed for additional organ transplant (i.e., heart, liver) current substance abuse or dependency known or suspected psychotic disorder known or suspected mental retardation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James R Rodrigue, Ph.D.
Organizational Affiliation
Beth Israel Deaconess Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Martha Pavlakis, MD
Organizational Affiliation
Beth Israel Deaconess Medical Center
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Didier Mandelbrot, MD
Organizational Affiliation
Beth Israel Deaconess Medical Center
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ogo Egbuna, MD
Organizational Affiliation
Beth Israel Deaconess Medical Center
Official's Role
Study Chair
Facility Information:
Facility Name
Beth Israel Deaconess Medical Center
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02215
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
22510472
Citation
Rodrigue JR, Pavlakis M, Egbuna O, Paek M, Waterman AD, Mandelbrot DA. The "House Calls" trial: a randomized controlled trial to reduce racial disparities in live donor kidney transplantation: rationale and design. Contemp Clin Trials. 2012 Jul;33(4):811-8. doi: 10.1016/j.cct.2012.03.015. Epub 2012 Apr 3.
Results Reference
derived

Learn more about this trial

A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation

We'll reach out to this number within 24 hrs